ITC Limited Q4 & FY26 Financial Performance and Strategic Growth Updates
ITC Limited delivered a resilient performance for the fiscal year ended March 31, 2026, reporting a 10.1% increase in standalone Gross Revenue…
Himadri Speciality Chemical Ltd 38th Annual General Meeting Scheduled for June 2026
Himadri Speciality Chemical Ltd has announced that its 38th Annual General Meeting will be held on June 11, 2026, at 11:00 a.m. The meeting…
NHPC Limited Robust Financial Performance for Fiscal Year Ended March 31, 2026
NHPC Limited has announced its financial results for the quarter and year ended March 31, 2026. The company reported a strong annual net…
PTC India Limited Annual Secretarial Compliance Report Released for FY 2026
PTC India Limited has released its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms that…
Adani Power Acquires Power Assets and Stake in Jaiprakash Power Ventures
Adani Power Limited has entered into definitive agreements to acquire a 24% equity stake in Jaiprakash Power Ventures Limited and a 180 MW…
IRB Infrastructure Developers Ltd Audio Recording of Q4 FY26 Earnings Call Now Available
IRB Infrastructure Developers Ltd has released the audio recording of its earnings conference call held on May 21, 2026. The session, which…
ITC Limited Board Approves Financial Results and Recommends Final Dividend
ITC Limited has announced its audited financial results for the year ended March 31, 2026. The Board of Directors has recommended a final…
ITC Limited Reports Strong Performance for the Year Ended March 31, 2026
ITC Limited has reported robust financial results for the fiscal year ended March 31, 2026. The company achieved a consolidated annual profit…
Crompton Greaves Consumer Electricals Limited Annual Secretarial Compliance Report Released
Crompton Greaves Consumer Electricals Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31,…
Alembic Pharmaceuticals Limited Q4 FY ’26 Earnings and Strategic Outlook
Alembic Pharmaceuticals reported a resilient 4% year-on-year revenue growth to INR 1,838 crore for Q4 FY ’26. The company successfully…